Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €115.00.

In a report released yesterday, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), ...

Roman Chicz, Global Head, External Research and Development, Tel: +1-617-866-4562, Email: [email protected];Jean-Louis Grunwald, Vice President, Business Development, Tel: +65 64 31 22 10 ...

This leadership has translated into outstanding success in the industry. Sanofi Pasteur is interested in partners who will share in the pursuit of innovation and the company’s drive for ...

Sanofi Pasteur and Merial will continue as Sanofi's vaccines and animal health products divisions, respectively, headed by their current bosses Olivier Charmeil and Carsten Hellmann. Sanofi has ...

costly patent expirations of top-selling products as are some rivals. "We've spent five years as a team getting Sanofi to the start line of being a respected R&D machine, and I think the markets ...

The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was ...

Sanofi Pasteur and MSD have officially ended their European vaccines joint venture, which had been in place for more than two decades. The companies announced they were to end the Sanofi Pasteur ...

Regeneron REGN1.05%increase; green up pointing triangle Pharmaceuticals and Sanofi SAN-0.46%decrease; red down pointing triangle have won U.S. Food and Drug Administration expanded approval of ...